S4513 (2023-24 session)
NY State bill
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
- Title
- Preserves access to affordable drugs
- Type
- New York State Senate bill
- Session
- 2023-24 session
- Status
- In Senate Committee
- Latest action date
- 2024-05-15
- In committee
- Finance
- Introduced
- 2023-02-09
- Same as
- A7465
- Law section
- Public Health Law
Sponsors
- Nathalia Fernandez State Senator, District 34
Co-sponsors
Heard in committee
Same as
- A7465 (2023-24 session) NY State bill
Committee meetings
Committee meetings that took this bill up, from the Senate's published agendas. The Assembly does not publish its committee agendas in machine-readable form, so an Assembly committee's consideration of a bill is not on this list.
- Health, 2024-05-15 Referred to committee; referred to Finance
- Health, 2023-05-17 First reading